Development and use of an internal positive control for detection of Bordetella pertussis by PCR

Stéphanie Herwegh1, Christophe Carnoy, Frédéric Wallet

  • 1Laboratoire de Bactériologie-Hygiène, Hôpital A. Calmette, F-59037-Lille Cedex, France.

Insights

An internal control using recombinant PCR was developed to detect PCR inhibitors. This method was successfully applied to diagnose whooping cough by amplifying Bordetella pertussis DNA.

Area of Science:

  • Molecular Biology
  • Diagnostic Microbiology

Background:

  • Polymerase Chain Reaction (PCR) is a powerful tool for DNA amplification.
  • The presence of PCR inhibitors in clinical samples can lead to false-negative results.
  • Accurate detection of infectious agents requires reliable amplification methods.

Purpose of the Study:

  • To develop and validate an internal control for PCR amplification.
  • To assess the utility of this control in detecting PCR inhibitors.
  • To apply the method for the diagnosis of whooping cough.

Main Methods:

  • Construction of an exogenous DNA internal control using recombinant PCR.
  • Coamplification of the internal control with the target gene in the same reaction mixture.
  • Application of the method to detect Bordetella pertussis IS481 DNA.

Main Results:

  • The internal control effectively detected the presence of PCR inhibitors.
  • The method demonstrated successful coamplification with the target gene.
  • The assay was successfully applied to the diagnosis of whooping cough.

Conclusions:

  • Recombinant PCR-based internal controls are effective for detecting PCR inhibitors.
  • This approach enhances the reliability of PCR-based diagnostic tests.
  • The developed method provides a robust tool for whooping cough diagnosis.